本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mira Pharma

0.7738
-0.0154-1.95%
盤後0.77380.00000.00%19:02 EDT
成交量:10.57萬
成交額:8.34萬
市值:3,240.37萬
市盈率:-0.56
高:0.8200
開:0.7893
低:0.7738
收:0.7892
52周最高:2.45
52周最低:0.6000
股本:4,187.61萬
流通股本:3,494.42萬
量比:0.44
換手率:0.30%
股息:- -
股息率:- -
每股收益(TTM):-1.3802
每股收益(LYR):-1.3505
淨資產收益率:-217.12%
總資產收益率:-129.55%
市淨率:3.97
市盈率(LYR):-0.57

資料載入中...

2024/03/13

重要事件披露

Form 8-K - Current report
2024/03/07

重要事件披露

Form 8-K - Current report
2024/01/17

重要事件披露

Form 8-K - Current report
2023/12/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/22

SEC問詢函

Form CORRESP - Correspondence
2023/12/19

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/20

重要事件披露

Form 8-K - Current report
2023/11/20

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/16

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/14

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/08

重要事件披露

Form 8-K - Current report
2023/07/31

SEC問詢函

Form CORRESP - Correspondence
2023/07/31

SEC問詢函

Form CORRESP - Correspondence
2023/07/29

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/25

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]